Health Advice



How COVID is helping us move away from white-centered clinical trials to reach more patients

Sarah Gantz, The Philadelphia Inquirer on

Published in Health & Fitness

Conner and her daughter are involved in a similar ambassador program at Fox Chase Cancer Center.

They go to churches and share their personal stories through the nonprofit they started, Praise Is the Cure, to help people feel comfortable asking questions they may not want to ask doctors.

Matchett, now 47, had a double mastectomy in 2008 to treat her aggressive form of cancer. At the time, she was 33 with a 2-year-old daughter. Almost a decade later, the cancer resurfaced in her lungs, and in 2020, it spread to her spine.

Matchett’s first reaction was tears, then gratitude toward her mother, whose involvement in a clinical trial helped doctors learn more about how to treat the next generation of breast cancer patients.

“There was no way I could go through all the treatment procedures my mom did,” Matchett recalled. “And the doctor said, “You won’t have to do any of that because of all the advancement.”


Matchett now has three children, ages 16, 11, and 10, who she says have never known a mother without cancer.

Matchett and her doctors are exploring clinical trial options in addition to chemotherapy, because she wants her children to see her resilience and her determination to help herself and others — just as her mother did.


©2022 The Philadelphia Inquirer, LLC. Visit at Distributed by Tribune Content Agency, LLC.


blog comments powered by Disqus